SYNCOM FORMULATIONS (INDIA) . Q2 FY25 Results
SYNCOM FORMULATIONS (INDIA) . has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 102.31 Cr
- Quarter-on-Quarter (QoQ) Change: 17.26% (Previous Quarter: Rs. 87.26 Cr )
- Year-on-Year (YoY) Change: 60.27% (Same Quarter Last Year: Rs. 63.84 Cr )
Profitability Metrics
- Net Profit: Rs. 11.11 Cr
- QoQ Profit Change: 45.54% (Previous Quarter: Rs. 7.63 Cr )
- YoY Profit Change: 70.59% (Same Quarter Last Year: Rs. 6.51 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 0.16
- QoQ EPS Change: 45.45% (Previous Quarter: Rs. 0.11)
- YoY EPS Change: 100.00% (Same Quarter Last Year: Rs. 0.08)
Performance Summary
Exceptional
SYNCOM FORMULATIONS (INDIA) . showed amazing growth in profits, beating even the strong sales increase. This means the company is making more money from each sale.
This analysis provides a snapshot of SYNCOM FORMULATIONS (INDIA) .'s financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.